Mar 24, 2025 · Jump To TD-Specific Meds New Antipsychotics Brain Stimulation Outlook It can be scary when you or a loved one has been diagnosed with tardive dyskinesia (TD), a disorder characterized …

Sep 18, 2023 · Discover cutting-edge treatments for tardive syndrome. Learn about FDA-approved meds, personalized approaches, and future perspectives in one place.

Nov 20, 2025 · Explore the unique benefits of Ingrezza, a VMAT2 inhibitor for tardive dyskinesia, and how it compares to other treatment options.

Jul 14, 2025 · Medications for Parkinsonism worsen tardive dyskinesia symptoms, and vice versa. Only 2 FDA-approved medications for tardive dyskinesia sit on the market—tetrabenazine and …

Mar 20, 2025 · The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, …

Dec 2, 2025 · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led to …

May 13, 2025 · Treatment Strategies for Tardive Dyskinesia A comprehensive approach is essential to ensure early detection and management of this potentially permanent movement disorder while …

Jul 28, 2025 · Key Takeaways Tardive dyskinesia results from chronic dopamine-receptor blockade, causing involuntary movements, primarily in the oral-buccal-lingual areas. VMAT2 inhibitors, …

1 day ago · Tardive dyskinesia is a movement disorder caused most often by long-term use of certain medicines that block dopamine. If you have tardive dyskinesia , you will notice repeated, involuntary …

Apr 25, 2025 · Older adults face an elevated risk of developing tardive dyskinesia (TD) — a common side effect of antipsychotic medications. New results – appearing this week in The Journal of CLinical …